Strategy Update: Annexin Pharmaceuticals

June 10 2021

07:45-09:15

Livesändning på Redeye.se

June 10 2021

07:45-09:15

Livesändning på Redeye.se

Livesändning på Redeye.se

Live events are available to Redeye members

Sign up for a free membership

Already a member?

Sign in

Livesändning på Redeye.se

Annexin Pharmaceuticals, a leading biotechnology company in the Annexin A5-field for treatment of various vascular diseases, gives a live update followed by a Q&A session.

CEO Anders Haegerstrand will present an update on the status of the company’s key projects and priorities. In addition, CMO/CSO Anna Frostegård will present activities and roadmap for the lead project in RVO (retinal vein occlusion) in preparation for the Phase 2 study.

The company presentation is followed by a Q&A session led by Redeye Analyst Fredrik Thor.

This event will be presented in English

 

Sign up to the event here

 

NOTE

Companies and schedules may change before the event starts. Save the date to your calendar by using Add to calendar.